In a nutshell This study examined the benefit of adding apalutamide (JNJ 56021927) to standard hormone therapy in men with castration-resistant prostate cancer (CRPC). Researchers reported preliminary evidence for apalutamide as a safe and effective additional hormone therapy for high-risk CRPC. Some background Hormone therapy is the standard of...
Read More
In a nutshell This study examined robotic assisted radical prostatectomy (RARP) in the treatment of high-risk localized prostate cancer. Researchers reported that the number of risk factors did not increase the risk of cancer recurrence after RARP. Some background Prostate surgery (also called radical prostatectomy) is a common treatment for...
Read More
In a nutshell This study evaluated whether the neutrophil-to-lymphocyte ratio (NLR) can predict disease recurrence after treatment with prostate surgery. Researchers reported a strong association between high NLR and disease recurrence after prostate surgery. Some background Neutrophils are cells that are involved in inflammation (reaction to...
Read More
How does a diagnosis of prostate cancer affect intimacy? Led by patient advocate Jeff Folloder, experts across several disciplines discuss sexuality and dysfunction. The panel explores how, in one form or another, this subject affects every single advanced prostate cancer patient and his partner. Learn how communication and support through...
Read More
In a nutshell This study investigated erectile function after prostate surgery in men with high-risk localized prostate cancer. Researchers reported high rates of erectile dysfunction following prostate surgery. Some background Surgical removal of the prostate gland is a common treatment for localized prostate cancer (cancer confined to the...
Read More
In a nutshell This study investigated the safety and effectiveness of high-intensity focused ultrasound (HIFU) in treating localized prostate cancer. Researchers concluded that HIFU is an effective treatment option, particularly for men not suitable for surgery or radiation therapy. Some background Localized prostate cancer is cancer that is...
Read More
In a nutshell The authors aimed to identify those melanoma patients having a low risk of cancer spreading to the lymph nodes. The authors found that most melanoma patients with intermediate tumor thickness (between 1.01 mm and 1.05 mm) had a similar risk of disease spread to the lymph nodes as found in patients with thin melanoma (tumor thickness of 1...
Read More
Published By : Cancer Date : Feb 25, 2016 Original Title : Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study. ...
Read More
In a nutshell This study investigated the appropriate waiting time to surgery after radiation and chemotherapy in rectal cancer patients. Researchers suggested that 56 days is the optimal waiting time for surgery after completion of radiation or chemotherapy. Some background Chemotherapy and radiation prior to surgery to remove rectal cancer has...
Read More
In a nutshell The authors aimed to determine overall mortality (patients who died after treatment) and prostate-specific mortality (patients who died from prostate cancer after treatment) in patients who underwent prostate surgery or radiation to treat localized (confined to the prostate) prostate cancer. The authors...
Read More
In a nutshell This study investigated the associations of weight loss with bone mineral density and bone turnover in overweight postmenopausal breast cancer survivors. The study concluded that weight loss did not have a negative effect on bone health. Some background Chemotherapy may cause some patients to go through menopause by disrupting female...
Read More
In a nutshell This study examined the potential benefit of early hormone therapy added to intensive radiotherapy in the treatment of men with intermediate-risk local prostate cancer. Overall survival was found to be improved with higher radiation dosage. However, the researchers noted that early hormone therapy does generally not benefit treatment...
Read More
